Events

DigitalHealthEurope Summit
SEP
Tue
28
SEP
Wed
29
SEP
Thu
30

This was 4 years ago

Location

Online

Programmes
Health Digital, Industry & Space Digital Europe Health

As the concluding peace of the DigitalHealthEurope project (DHE), which comes to an end in September 2021, a DHE Summit is organised to bring together EU policymakers, funders, digital health experts and other health stakeholders for forward-looking debates on digital transformation in the healthcare sector.

The Summit will focus on real-life transformations through digital health (Day 1), empowering citizens through health data (Day 2) and scaling up innovation through health data (Day 3).

The organiser, DigitalHealthEurope, is an EU-funded project (Horizon 2020 funding) with as main objective the deployment of digital solutions for person-centred integrated care.

More information and registration on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.